BamSEC and AlphaSense Join Forces
Learn More

Kadmon Holdings Inc

Formerly NASDAQ: KDMN
Search in Documents
Key Exhibits
External Links

Credit Agreements Filter

EX-10.41
from 10-K 6 pages Sixth Waiver Agreement to Credit Agreement
12/34/56
EX-10.1
from 8-K 13 pages Amendment #5 to Credit Agreement and Amendment to Warrant Certificate
12/34/56
EX-10.1
from 8-K 12 pages Amendment #4 to Credit Agreement
12/34/56
EX-10.59
from 10-K 8 pages Fifth Waiver Agreement to Credit Agreement
12/34/56
EX-10.1
from 8-K 12 pages  Amendment #3 to Credit Agreement and Amendment to Warrant Certificates
12/34/56
EX-10.20
from 10-K 8 pages Fourth Waiver Agreement to Credit Agreement
12/34/56
EX-10.3
from 10-Q 9 pages Amendment #2 to Credit Agreement
12/34/56
EX-10.2
from 10-Q 9 pages Third Waiver Agreement to Credit Agreement
12/34/56
EX-10.8
from S-1 52 pages First Lien/Second Lien Intercreditor Agreement August 28, 2015 Among Perceptive Credit Opportunities Fund, LP, as Class a Representative Macquarie US Trading LLC, as Class B Agent Cortland Capital Market Services LLC, as Second Lien Collateral Agent Perceptive Credit Opportunities Fund, LP, as Control Agent Kadmon Pharmaceuticals, LLC, as Borrower Kadmon Holdings, LLC, as Holdings Kadmon Corporation, LLC, Kadmon Research Institute, LLC, Three Rivers Research Institute I, LLC, Three Rivers Biologics, LLC, Three Rivers Global Pharma, LLC, as Guarantors
12/34/56
EX-10.6
from S-1 60 pages Amendment #2 to Credit Agreement
12/34/56
EX-10.5
from S-1 5 pages First Amendment to Credit Agreement
12/34/56
EX-10.4
from S-1 140 pages Third Amended and Restated Senior Secured Convertible Credit Agreement Dated as of August 28, 2015 Between Kadmon Pharmaceuticals, LLC as Borrower, the Guarantors From Time to Time Party Hereto, the Lenders From Time to Time Party Hereto, and Macquarie US Trading LLC, as Administrative Agent
12/34/56
EX-10.3
from S-1 131 pages Second Waiver and Consent Agreement to Credit Agreement
12/34/56
EX-10.2
from S-1 5 pages Amendment to Credit Agreement
12/34/56
EX-10.1
from S-1 111 pages Credit Agreement Dated as of August 28, 2015 Between Kadmon Pharmaceuticals, LLC as Borrower, the Guarantors From Time to Time Party Hereto, and the Lenders From Time to Time Party Hereto, Perceptive Credit Opportunities Fund, LP, as Collateral Representative U.S. $35,000,000
12/34/56
EX-10.4
from DRS/A 52 pages First Lien/Second Lien Intercreditor Agreement August 28, 2015 Among Perceptive Credit Opportunities Fund, LP, as Class a Representative Macquarie US Trading LLC, as Class B Agent Cortland Capital Market Services LLC, as Second Lien Collateral Agent Perceptive Credit Opportunities Fund, LP, as Control Agent Kadmon Pharmaceuticals, LLC, as Borrower Kadmon Holdings, LLC, as Holdings Kadmon Corporation, LLC, Kadmon Research Institute, LLC, Three Rivers Research Institute I, LLC, Three Rivers Biologics, LLC, Three Rivers Global Pharma, LLC, as Guarantors
12/34/56
EX-10.2
from DRS/A 140 pages Third Amended and Restated Senior Secured Convertible Credit Agreement Dated as of August 28, 2015 Between Kadmon Pharmaceuticals, LLC as Borrower, the Guarantors From Time to Time Party Hereto, the Lenders From Time to Time Party Hereto, and Macquarie US Trading LLC, as Administrative Agent
12/34/56
EX-10.1
from DRS/A 111 pages Credit Agreement Dated as of August 28, 2015 Between Kadmon Pharmaceuticals, LLC as Borrower, the Guarantors From Time to Time Party Hereto, and the Lenders From Time to Time Party Hereto, Perceptive Credit Opportunities Fund, LP, as Collateral Representative U.S. $35,000,000
12/34/56